I Gordon
Overview
Explore the profile of I Gordon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
367
Citations
2198
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Useni S, Odume B, Tukur M, Chukwu E, Nwokoye N, Ogbudebe C, et al.
Public Health Action
. 2025 Mar;
15(1):17-20.
PMID: 40028640
Setting: TB screening cascade and performance of active case-finding strategies across six states of Nigeria. Objective: To analyse the impact of portable digital X-ray (PDX) on TB screening in hard-to-reach...
2.
Omotayo S, Chukwuogo O, Ogbudebe C, Egbule D, Opara P, Bot T, et al.
Public Health Action
. 2025 Mar;
15(1):38-43.
PMID: 40028638
Setting: Despite recent progress in TB notification rates, 6.2% of the 3.1 million 'missing' people with TB globally are from Nigeria. Identifying these 'missing' cases will improve TB control efforts...
3.
Perception, acceptability and challenges of digital adherence technology among TB healthcare workers
Gordon I, Odume B, Ogbudebe C, Chukwuogo O, Nwokoye N, Useni S, et al.
Public Health Action
. 2024 Jul;
14(2):61-65.
PMID: 38957501
Introduction: Successful treatment of TB requires high levels of adherence to treatment. This has been found to be below optimal with directly observed therapy (DOT), and digital adherence technologies (DATs)...
4.
Ogbudebe C, Odume B, Gordon I, Chukwuogo O, Nwokoye N, Useni S, et al.
Public Health Action
. 2024 Jul;
14(2):66-70.
PMID: 38957499
Introduction: Poor adherence to TB treatment poses a significant public health threat to TB control programmes. The sustainability of directly observed treatment has been questioned because of its non-patient-centred approach...
5.
Hussain T, Jeganathan N, Karagkounis G, Stocchi L, Shawki S, Holubar S, et al.
Tech Coloproctol
. 2020 Jun;
24(10):1055-1062.
PMID: 32596760
Background: Small bowel adenocarcinoma (SBA) remains a rare entity but occurs at increased frequency in the setting of chronic Crohn's disease (CD). Our aim was to study the presentation, diagnosis...
6.
Pontier D, Gaillard J, Allaine D, Trouvilliez J, Gordon I, Duncan P
Oecologia
. 2017 Mar;
80(3):390-394.
PMID: 28312067
It is argued that the postnatal growth rate should be linked to maternal body weight by the exponent 0.75. This theoretically derived hypothesis is found to be consistent with published...
7.
Weinberg L, Story D, Gordon I, Christophi C
Anaesthesia
. 2016 Sep;
71(10):1238-9.
PMID: 27611042
No abstract available.
8.
Weinberg L, Rachbuch C, Ting S, Howard W, Yeomans M, Gordon I, et al.
Anaesthesia
. 2016 Jan;
71(4):405-10.
PMID: 26749026
We allocated 76 men scheduled for radical retropubic prostatectomy to peri-operative lidocaine 2% or saline 0.9%: a pre-operative 0.075 ml.kg(-1) intravenous bolus; an intra-operative intravenous infusion at 0.075 ml.kg(-1) .h(-1)...
9.
Ledgerwood J, Coates E, Yamshchikov G, Saunders J, Holman L, Enama M, et al.
Clin Exp Immunol
. 2015 Sep;
182(3):289-301.
PMID: 26332605
VRC-HIVMAB060-00-AB (VRC01) is a broadly neutralizing HIV-1 monoclonal antibody (mAb) isolated from the B cells of an HIV-infected patient. It is directed against the HIV-1 CD4 binding site and is...
10.
HODSON C, FRANCE N, Gordon I
J Fac Radiol
. 2014 Feb;
5(1):50-61.
PMID: 24542555
No abstract available.